Mesoblast (MESO) Return on Equity [ROE] (2016 - 2023)
Mesoblast (MESO) recorded Return on Equity [ROE] of -9.86% in the year ended Jun 30, 2026, up 9.09 percentage points from -18.95% a year earlier.
Powered by 
Analysis
Mesoblast (MESO) Return on Equity [ROE] (2016 - 2023) Analysis & Trends
Starting with the year ended Jun 30, 2015, Mesoblast's Return on Equity [ROE] history includes 12 years.
- Annual Return on Equity [ROE] has a five-year change of +7.61 percentage points (years ended Jun 2021 to Jun 2026).
- The figure for the year ended Jun 30, 2026 is the highest annual Return on Equity [ROE] in data going back to the year ended Jun 30, 2015.
- Per Business Quant data, MESO's Return on Equity [ROE] was -18.95% in the year ended Jun 30, 2025 (-1.04 pp), -17.91% in the year ended Jun 30, 2024 (-1.51 pp), -16.40% in the year ended Jun 30, 2023 (+0.54 pp) and -16.94% in the year ended Jun 30, 2022 (+0.54 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Mesoblast | 1.82 Bn | 1.39 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -16.67% |
| Mar 31, 2023 | -16.60% |
| Dec 31, 2022 | -16.47% |
| Sep 30, 2022 | -16.81% |
| Jun 30, 2022 | -18.04% |
| Mar 31, 2022 | -17.52% |
| Dec 31, 2021 | -17.83% |
| Sep 30, 2021 | -17.04% |
| Jun 30, 2021 | -16.99% |
| Mar 31, 2021 | -20.97% |
| Dec 31, 2020 | -20.78% |
| Sep 30, 2020 | -20.85% |
| Jun 30, 2020 | -18.66% |
| Mar 31, 2020 | -17.14% |
| Dec 31, 2019 | -19.45% |
| Sep 30, 2019 | -20.11% |
| Jun 30, 2019 | -21.94% |
| Mar 31, 2019 | -20.19% |
| Dec 31, 2018 | -19.41% |
| Sep 30, 2018 | -19.52% |
API Access
Mesoblast Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MESO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "MESO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MESO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();